200 related articles for article (PubMed ID: 18665089)
1. Exocrine-endocrine pancreatic cancer and alpha-fetoprotein.
Brandi G; Nobili E; Capizzi E; Corti B; Di Cicilia R; Di Marco M; Biasco G
Pancreas; 2008 Aug; 37(2):223-5. PubMed ID: 18665089
[No Abstract] [Full Text] [Related]
2. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal carcinoma: from the bench to the bedside.
Pezzilli R
JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
[No Abstract] [Full Text] [Related]
4. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas.
Katayama M; Funakoshi A; Sumii T; Sanzen N; Sekiguchi K
Cancer Lett; 2005 Jul; 225(1):167-76. PubMed ID: 15922869
[TBL] [Abstract][Full Text] [Related]
5. Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.
Gao DJ; Xu M; Zhang YQ; Du YQ; Gao J; Gong YF; Man XH; Wu HY; Jin J; Xu GM; Li ZS
Pancreas; 2010 Oct; 39(7):994-1001. PubMed ID: 20467347
[TBL] [Abstract][Full Text] [Related]
6. Management of pancreatic neuroendocrine tumors.
Dabizzi E; Panossian A; Raimondo M
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):467-79. PubMed ID: 21139544
[TBL] [Abstract][Full Text] [Related]
7. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
8. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
[No Abstract] [Full Text] [Related]
9. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
11. Endocrine tumors of the pancreas.
Simon P; Spilcke-Liss E; Wallaschofski H
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):431-47, xii. PubMed ID: 16632104
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas.
Pavel ME; Hassler G; Baum U; Hahn EG; Lohmann T; Schuppan D
Clin Endocrinol (Oxf); 2005 Apr; 62(4):434-43. PubMed ID: 15807874
[TBL] [Abstract][Full Text] [Related]
13. Perspectives in chemotherapy of pancreatic cancer.
Klapdor R
Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
[No Abstract] [Full Text] [Related]
14. [Increase of alpha-fetoprotein in pancreatic endocrine tumors with hepatic metastases. Apropos of 2 cases].
Lesur G; Bergemer AM; Turner L; Parlier H; Bernades P; Dupuy P
Gastroenterol Clin Biol; 1996 Mar; 20(2):204-6. PubMed ID: 8761683
[TBL] [Abstract][Full Text] [Related]
15. Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence.
Power DG; Shia J; Allen PJ; Jarnagin WR; O'Reilly EM
Clin Colorectal Cancer; 2011 Jun; 10(2):146-50. PubMed ID: 21859569
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein producing pancreatic neuroendocrine tumour.
Wang CY; Lin JC; Li YF; Yang CW
QJM; 2020 Aug; 113(8):565-566. PubMed ID: 31999348
[No Abstract] [Full Text] [Related]
17. Protein biomarker for pancreatic ductal adenocarcinoma.
Burki T
Lancet Oncol; 2017 Sep; 18(9):e511. PubMed ID: 28736187
[No Abstract] [Full Text] [Related]
18. Intraductal papillary mucinous neoplasms of the pancreas: should we side step the side branches?
Bishop MD; Wallace MB
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):724-5. PubMed ID: 18602034
[No Abstract] [Full Text] [Related]
19. [Existance of alpha 1-fetoprotein in the absence of hepatoma].
Andrieu J; Breart G; Rodier B; Robert PE
Presse Med (1893); 1971 Aug 28-Sep 4; 79(36):1595-6. PubMed ID: 4143480
[No Abstract] [Full Text] [Related]
20. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours.
Oberg K
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S17-25. PubMed ID: 22005113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
